Related Experiment Video
Updated: Apr 16, 2026
07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
4.5K
Atrial Septostomy: A Contemporary Review
Hayan Al Maluli1, Christine M DeStephan2, René J Alvarez1
1Department of Internal Medicine, Cardiology Division, Temple University Hospital, Philadelphia, Pennsylvania.
Clinical Cardiology
|March 4, 2015
Summary
Pulmonary arterial hypertension (PAH) is a serious condition. Atrial septostomy offers a palliative option by decompressing the right ventricle, with ongoing research into related interventions.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Interventional Cardiology
Background:
- Pulmonary arterial hypertension (PAH) presents significant morbidity and mortality.
- While medical therapies have advanced, invasive procedures remain crucial for select PAH patients.
- Atrial septostomy is a palliative procedure to decompress the right ventricle in PAH.
Purpose of the Study:
- To provide a comprehensive overview of atrial septostomy for pulmonary arterial hypertension.
- To discuss the history, indications, contraindications, techniques, and outcomes of atrial septostomy.
- To explore emerging palliative interventions for PAH based on atrial septostomy principles.
Main Methods:
- Review of historical data and current literature on atrial septostomy.
- Analysis of procedural techniques and patient outcomes.
- Discussion of novel palliative strategies inspired by atrial septostomy.
Main Results:
- Atrial septostomy creates a right-to-left shunt, decompressing the right ventricle in PAH.
- Despite improvements and reports of better outcomes, adoption of atrial septostomy is slow.
- Newer interventions utilizing similar physiological concepts are under evaluation.
Conclusions:
- Atrial septostomy remains a valuable palliative option for advanced pulmonary arterial hypertension.
- Further research and clinical evaluation are needed for atrial septostomy and related interventions.
- Optimizing the use of palliative procedures is essential for managing complex PAH cases.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
484
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
484
01:22Mitral Stenosis I: Introduction
1.6K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
01:25Mitral Regurgitation III: Medical Management
617
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
617
01:20Mitral Regurgitation I: Introduction
1.2K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
01:22Mitral Valve Prolapse II: Assessment and Management
1.3K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.3K
01:25Aortic Regurgitation III: Medical Management
562
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562